These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 5412628)

  • 1. Investigations on the effect of some drugs on the Parkinsonian rigidity.
    Boman K; Meurman T
    Acta Neurol Scand; 1970; 46(1):71-84. PubMed ID: 5412628
    [No Abstract]   [Full Text] [Related]  

  • 2. [Neurological aspects and modern trends in therapy of Parkinson's disease].
    Pavoncello S; Di Bianco V; Di Castro A; Caviglia A; Cellitti M
    Clin Ter; 1980 Feb; 92(4):433-8. PubMed ID: 7449321
    [No Abstract]   [Full Text] [Related]  

  • 3. Excessive use of anticholinergic drugs in a sub-sample of Italian schizophrenics.
    Schifano F; di Costanzo E
    Int J Clin Pharmacol Ther Toxicol; 1991 May; 29(5):184-6. PubMed ID: 2071270
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Treatment of parkinsonism].
    Parkenberg H
    Ugeskr Laeger; 1976 Apr; 138(18):1104-5. PubMed ID: 1265907
    [No Abstract]   [Full Text] [Related]  

  • 5. Evaluating the long-term need for antiparkinson drugs by chronic schizophrenics.
    Klett CJ; Caffey E
    Arch Gen Psychiatry; 1972 Apr; 26(4):374-9. PubMed ID: 4552131
    [No Abstract]   [Full Text] [Related]  

  • 6. Experiences with cogentin in the treatment of Parkinsonism. A one-year controlled study of 94 patients.
    Strang RR
    Acta Neurol Scand; 1966; 41(4):413-8. PubMed ID: 4393610
    [No Abstract]   [Full Text] [Related]  

  • 7. Double-blind comparison of levodopa and procyclidine in parkinsonism, with illustrations of levodopa-induced movement disorders.
    Timberlake WH
    Neurology; 1970 Dec; 20(12):31-5. PubMed ID: 4924342
    [No Abstract]   [Full Text] [Related]  

  • 8. A controlled trial of anti-Parkinson drugs in drug-induced Parkinsonism.
    Ekdawi MY; Fowke R
    Br J Psychiatry; 1966 Jun; 112(487):633-6. PubMed ID: 5964267
    [No Abstract]   [Full Text] [Related]  

  • 9. [Dyskinesia induced by anticholinergic drugs--electrophysiological analysis].
    Mano T
    Rinsho Shinkeigaku; 1974 Mar; 14(3):255-65. PubMed ID: 4153837
    [No Abstract]   [Full Text] [Related]  

  • 10. Antiparkinsonism drugs.
    Med Lett Drugs Ther; 1965 Mar; 7(6):22-4. PubMed ID: 5831354
    [No Abstract]   [Full Text] [Related]  

  • 11. Abnormal involuntary movements induced by anticholinergic therapy.
    Birket-Smith E
    Acta Neurol Scand; 1974; 50(6):801-11. PubMed ID: 4155220
    [No Abstract]   [Full Text] [Related]  

  • 12. [Long-acting antiparkinson agents. I. Pilot study on benzetimide (342 cases)].
    Korn M; Pinchard A; Breulet M; Goffioul F; Bobon J
    Acta Psychiatr Belg; 1971 Mar; 71(2):65-75. PubMed ID: 5560276
    [No Abstract]   [Full Text] [Related]  

  • 13. Withdrawal of antiparkinson drugs.
    Orlov P; Kasparian G; DiMascio A; Cole JO
    Arch Gen Psychiatry; 1971 Nov; 25(5):410-2. PubMed ID: 5133814
    [No Abstract]   [Full Text] [Related]  

  • 14. [Treatment of neuroleptic induced acute dystonia].
    Malm U
    Lakartidningen; 1969 Nov; 66(46):4714. PubMed ID: 5375330
    [No Abstract]   [Full Text] [Related]  

  • 15. Mefexamide as an antiparkinson drug. (A double-blind study).
    Denber HC; Mohr CP
    Dis Nerv Syst; 1969 Apr; 30(4):250-3. PubMed ID: 4890010
    [No Abstract]   [Full Text] [Related]  

  • 16. Effect of gastric motility on levodopa.
    Fermaglich J; O'Doherty DS
    Dis Nerv Syst; 1972 Sep; 33(9):624-5. PubMed ID: 4649158
    [No Abstract]   [Full Text] [Related]  

  • 17. [Experiences with ethybenzatropine (Ponalid) in the treatment of Parkinson's syndrome].
    Avenarius HJ; Gerstenbrand F
    Wien Klin Wochenschr; 1969 Sep; 81(36):622-5 passim. PubMed ID: 5810005
    [No Abstract]   [Full Text] [Related]  

  • 18. Visual hallucinations and delirium during treatment with amantadine (Symmetrel).
    Postma JU; Van Tilburg W
    J Am Geriatr Soc; 1975 May; 23(5):212-5. PubMed ID: 123540
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [What success does L-Dopa have in the treatment of parkinsonian akinesia?].
    Aebert K
    Dtsch Med Wochenschr; 1967 Mar; 92(11):483-7. PubMed ID: 6019685
    [No Abstract]   [Full Text] [Related]  

  • 20. Measurement of rigidity and tremor in Parkinson's disease.
    Aquilonius SM; Tiselius P
    Acta Neurol Scand; 1969; 45(3):327-34. PubMed ID: 5807452
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.